✦ LIBER ✦

Evidence that prokineticin receptor 2 exists as a dimer in vivo

✍ Scribed by Sara Marsango; Maria Carmela Bonaccorsi di Patti; Donatella Barra; Rossella Miele

Publisher: Springer
Year: 2010
Tongue: English
Weight: 1002 KB
Volume: 68
Category: Article
ISSN: 1420-682X
DOI: 10.1007/s00018-010-0601-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Evidence that prokineticin r

Erratum to: Evidence that prokineticin receptor 2 exists as a dimer in vivo

✍ Sara Marsango; Maria Carmela Bonaccorsi di Patti; Donatella Barra; Rossella Miel 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 93 KB

Evidence that the fusion protein of resp

Evidence that the fusion protein of respiratory syncytial virus exists as a dimer in its native form

✍ R. G. Arumugham; S. W. Hildreth; P. R. Paradiso 📂 Article 📅 1989 🏛 Springer Vienna 🌐 English ⚖ 1013 KB

In vivo evidence thatIds3fromHordeum vul

In vivo evidence thatIds3fromHordeum vulgareencodes a dioxygenase that converts 2′-deoxymugineic acid to mugineic acid in transgenic rice

✍ Takanori Kobayashi; Hiromi Nakanishi; Michiko Takahashi; Shinji Kawasaki; Naoko- 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 199 KB

In vitro evidence that 5-hydroxytryptami

In vitro evidence that 5-hydroxytryptamine increases efflux of glial glutamate via 5-HT2A receptor activation

✍ R. Meller; P.J. Harrison; J.M. Elliott; T. Sharp 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

## Abstract Recent studies have established the presence of 5‐hydroxytryptamine (5‐HT)~2A~ receptors on glial cells in culture and in the brain in situ. Here we used cultured C6 glioma cells to investigate the possibility that 5‐HT~2A~ receptors on glia regulate glutamate release from the cell. The

Evidence that ranolazine behaves as a we

Evidence that ranolazine behaves as a weak β1- and β2-adrenoceptor antagonist in the rat cardiovascular system

✍ Robert Létienne; Bruno Vié; Aline Puech; Sylvie Vieu; Bruno Le Grand; Gareth W. 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 185 KB

Blocking of interleukin 2 (IL 2) binding

Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18

✍ Athanasia Mouzaki; Hans-Dieter Volk; Hisao Osawa; Tibor Diamantstein 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

A mouse anti-rat interleukin 2 (IL 2) receptor (IL 2R) monoclonal antibody (mAb), ART-65, has been developed. As shown by fluorescence-activated cell sorter analysis and immunoprecipitation studies, ART-65 recognizes in a species-specific manner the same molecule as does ART-18, a mAb which has been